As we drove through southwest Memphis, KeShaun Pearson told me to keep my window down—our destination was best tasted, not viewed. Along the way, we passed an abandoned coal plant to our right, then ...
Source code related tasks for machine learning have become important with the large need of software production. In this project our main goal is to create a dataset for bug detection and repair and ...
In this tutorial, we demonstrate how to move beyond static, code-heavy charts and build a genuinely interactive exploratory data analysis workflow directly using PyGWalker. We start by preparing the ...
In these politically divisive times, there’s one thing we all agree on—we don’t want a giant data center in our backyard. Behold, the hyperscale data center! Massive structures, with thousands of ...
In the golden hills of Puglia, a southern region of Italy known today for its olive trees, white cliffs and turquoise mediterranean coves, Lorenzo Avello has artificial intelligence on his mind.
BOSTON, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with ...
Demonstration Project: Showcasing Beastmaster framework integration capabilities with ServiceNow for network infrastructure management. beast-unifi-integration/ ├── src/ │ ├── beast_unifi/ # UniFi API ...
RNA sequencing (RNA-Seq) is a high-throughput sequencing approach that enables comprehensive quantification of transcriptomes at a genome-wide scale. As a result, RNA-Seq has become a routine ...
Databricks has added a new agent, the Data Science Agent, to the Databricks Assistant, in an effort to help data practitioners automate analytics tasks. The agent, which is available now in preview ...
If you’d like an LLM to act more like a partner than a tool, Databot is an experimental alternative to querychat that also works in both R and Python. Databot is designed to analyze data you’ve ...
ABSTRACT: Evaluating drug safety during pregnancy remains an ongoing clinical and pharmacological challenge due to ethical, practical, and regulatory barriers, resulting in scarce human clinical trial ...